Investors who have owned stocks in the past year have generally experienced some big gains. But there is no question some big-name cryptocurrencies have left the stock market in the dust.
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers.
Following the market opening Thursday, the Dow traded down 0.27% to 35,390.70 while the NASDAQ fell 0.29% to 14,722.22. The S&P also fell, dropping 0.17% to 4,440.19.